Yi-Hsin Liang (@yihsinliang1) 's Twitter Profile
Yi-Hsin Liang

@yihsinliang1

I am passionate about research, participating as co-investigator in several clinical trials in the treatment of colorectal cancer and gastric cancer.

ID: 1111558685631938560

linkhttps://scholars.lib.ntu.edu.tw/cris/rp/rp199980?&locale=en calendar_today29-03-2019 09:20:17

53 Tweet

51 Takipçi

110 Takip Edilen

Guardant Health AMEA (@guardantamea) 's Twitter Profile Photo

Hear from Dr. Yi-Hsin Liang, a leading medical oncologist from Taiwan, as he shares about the benefits of using comprehensive liquid biopsies like the Guardant360® test for patients with advanced stage colorectal cancer.

Yi-Hsin Liang (@yihsinliang1) 's Twitter Profile Photo

It's a brilliant step that we could achieve the precision cancer treatment by non-invasive procedures! #colorectalcancer #PrecisionMedicine

SABCS (@sabcssanantonio) 's Twitter Profile Photo

Yen-Shen Lu, MD of NTU Hospital presents “Primary Results From Randomized Phase II RIGHT Choice Trial of Premenopausal Patients With Aggressive HR+/HER2-Advanced Breast Cancer Treated With Ribociclib + Endocrine Therapy vs Physician's Choice Combination Chemotherapy” #SABCS22

Yen-Shen Lu, MD of <a href="/NTU_Hospital/">NTU Hospital</a> presents “Primary Results From Randomized Phase II RIGHT Choice Trial of Premenopausal Patients With Aggressive HR+/HER2-Advanced Breast Cancer Treated With Ribociclib + Endocrine Therapy vs Physician's Choice Combination Chemotherapy” #SABCS22
Yi-Hsin Liang (@yihsinliang1) 's Twitter Profile Photo

East Asia Oncology Phase I trials Conference!!! After 4 years of COVID-19 panendemic crisis, we meet each other again safely !! James CH Yang

East Asia Oncology Phase I trials Conference!!!
After 4 years of COVID-19 panendemic crisis, we meet each other again safely !!
<a href="/James_CH_Yang/">James CH Yang</a>
Yi-Hsin Liang (@yihsinliang1) 's Twitter Profile Photo

Different goals, in different settings. My talk focused on neoadjuvant setting of immunotherapy. #tsitc #Immunotherapy #colorectalcancer

Different goals, in different settings. My talk focused on neoadjuvant setting of immunotherapy. #tsitc #Immunotherapy #colorectalcancer
Yi-Hsin Liang (@yihsinliang1) 's Twitter Profile Photo

Great work of immunotherapy for metastatic gastric cancer in Real world practice level from Japan colleagues. Nivolumab did improve the overall survival for mGC! #gastriccancer, #Nivolumab, #Immunotherapy

Great work of immunotherapy for metastatic gastric cancer in Real world practice level from Japan colleagues. Nivolumab did improve the overall survival for mGC! #gastriccancer, #Nivolumab, #Immunotherapy
Sharlene Gill, MD, MPH, MBA, FASCO (@gillsharlene) 's Twitter Profile Photo

#ASCO23 #CRCsm OncoAlert ➡️ can we better identify pts for EGFR⛔️beyond tissue RAS testing? ?🩸🧬 vs tumour 🧬 #PARADIGM #FIRE4 📌 need to recognize discordance 📌 tissue profiling is the standard ?NeoRAS - #GOZILA 📌 more data needed ➡️ excellent discussion by Dr Strickler

#ASCO23 #CRCsm <a href="/OncoAlert/">OncoAlert</a> 
➡️ can we better identify pts for EGFR⛔️beyond tissue RAS testing? 
?🩸🧬 vs tumour 🧬 #PARADIGM #FIRE4 
📌 need to recognize discordance
📌 tissue profiling is the standard
?NeoRAS - #GOZILA
📌 more data needed
➡️ excellent discussion by Dr Strickler
Yi-Hsin Liang (@yihsinliang1) 's Twitter Profile Photo

The main reason of discordance from tissue assay and liquid biopsy comes from the definitions. The cut-point of tissue asay is >5%. However, liquid biopsy can detect VAF lower than 0.1%! The cut-point of liquid biopsy is crucial!! #ASCO23 #PARADIGM #CRC #PrecisionMedicine

Yi-Hsin Liang (@yihsinliang1) 's Twitter Profile Photo

Fruitful discussion and interaction in this molecular tumor board with Mehlika Hazar Rethinam. The serial and dynamic change of genetic alterations are crucial for treatment for BRAF mutant metastatic colorectal cancer BRAF. #Liquidbiopsy #PrecisionMedicine #CRCsm #Colorectalcancer

Fruitful discussion and interaction in this molecular tumor board with <a href="/HazarMehlika/">Mehlika Hazar Rethinam</a>. The serial and dynamic change of genetic alterations are crucial for treatment for BRAF mutant metastatic colorectal cancer BRAF. #Liquidbiopsy #PrecisionMedicine #CRCsm #Colorectalcancer
Yi-Hsin Liang (@yihsinliang1) 's Twitter Profile Photo

The biggest cohort in the world published comparing the firstline anti-EGFR vs bevacizumab for patients with KRAS wild type mCRC. Over six thousand cases demonstrated the superior mOS from anti-EGFR!! CancerMedicine #Colorectalcancer #crcsm #mCRC onlinelibrary.wiley.com/doi/10.1002/ca…

Yi-Hsin Liang (@yihsinliang1) 's Twitter Profile Photo

The first positive IO plus platium-based chemotherapy combination for patient swith mUC!! Looking forward for the results to be disclosed! But why negative for Keynote-361 IMvigor 130???

アニメ「進撃の巨人」公式アカウント (@anime_shingeki) 's Twitter Profile Photo

/ 巨人を一匹残らず駆逐してやる⚔️ \ The Final Season完結編(後編)放送まで 10年を振り返る映像を公開します! 本日はエレン・イェーガー! The Final Season完結編(後編) 11月4日(土)24時より NHK総合にてスペシャル放送! #shingeki #aot #AttackOnTitan

Yi-Hsin Liang (@yihsinliang1) 's Twitter Profile Photo

"Unresectable" is actually a spectrum from disseminated diseases to borderline unresectable, such as liver-dominant diseases. To compensate this, much larger sample size is needed, just as PARADIGM did. #ESMO23 #crcsm #mcrc #colorectalcancer

Yi-Hsin Liang (@yihsinliang1) 's Twitter Profile Photo

Best friend ever & forever! This not his first time in Taiwan but the first time his birthday in Taiwan! Keep working hard for mCRC treatment together~ #CRCSM HiroyaTaniguchi #TSCRS #NTUH #mCRC

Best friend ever &amp; forever! This not his first time in Taiwan but the first time his birthday in Taiwan! Keep working hard for mCRC treatment together~ #CRCSM   <a href="/HiroyaTaniguchi/">HiroyaTaniguchi</a> #TSCRS #NTUH #mCRC